Burning Rock Biotech Ltd ADR (BNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,536 | 86,651 | 134,151 | 225,828 | 295,051 |
| Marketable Securities | N/A | N/A | N/A | 10,005 | 55,499 |
| Receivables | 20,826 | 17,868 | 15,942 | 14,468 | 13,520 |
| Inventories | 8,580 | 9,721 | 18,895 | 19,335 | 10,425 |
| Other current assets | 1,898 | 3,204 | 6,054 | 6,652 | 3,485 |
| TOTAL | $106,397 | $124,523 | $182,504 | $285,748 | $386,769 |
| Non-Current Assets | |||||
| PPE Net | 6,460 | 18,579 | 36,512 | 51,068 | 17,085 |
| Investments And Advances | 0 | 47 | 100 | 143 | 217 |
| Intangibles | 58 | 136 | 288 | 808 | 530 |
| Other Non-Current Assets | 8,373 | 3,197 | 10,758 | 19,795 | 3,528 |
| TOTAL | $14,891 | $21,959 | $47,658 | $71,814 | $21,360 |
| Total Assets | $121,288 | $146,482 | $230,162 | $357,562 | $408,129 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 372 | 6,447 |
| Accounts payable and accrued liabilities | 4,623 | 2,544 | 7,387 | 9,899 | 5,438 |
| Accrued Expenses | 12,262 | 14,780 | 25,203 | 20,070 | 12,820 |
| Other current liabilities | 81 | 169 | 261 | 153 | 172 |
| TOTAL | $36,484 | $37,095 | $59,655 | $58,406 | $37,018 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 16,152 | 18,386 | 21,405 | 22,420 | 11,403 |
| Other Non-Current Liabilities | 5,230 | 1,158 | 2,563 | 9,587 | 75 |
| TOTAL | $5,230 | $1,158 | $2,563 | $9,587 | $75 |
| Total Liabilities | $41,714 | $38,253 | $62,218 | $67,993 | $37,093 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 10,264 | 10,511 | 10,500 |
| Common Shares | 20 | 19 | 20 | 21 | 21 |
| Retained earnings | -575,433 | -542,773 | -463,949 | -349,733 | -217,343 |
| Other shareholders' equity | -21,319 | -23,032 | -23,569 | -32,494 | -25,683 |
| TOTAL | $79,574 | $108,229 | $167,944 | $289,569 | $371,036 |
| Total Liabilities And Equity | $121,288 | $146,482 | $230,162 | $357,562 | $408,129 |